Skip to Content

Litifilimab

https://www.medicalbillingandcodingcertification.net/web/image/product.template/261330/image_1920?unique=778ea14
Litifilimab (BIIB059) is a humanized anti-BDCA2 IgG1 monoclonal antibody administered subcutaneously. Litifilimab can inhibit the production of type I interferons, cytokines and chemokines. Litifilimab can be used in the research of disorders such as systemic lupus erythematosus[1][2].

1,967.60 € 1967.6 EUR 1,967.60 €

1,967.60 €

Not Available For Sale

This combination does not exist.

Terms and Conditions
30-day money-back guarantee
Shipping: 2-3 Business Days